Advancements and challenges in amyotrophic lateral sclerosis
D Bradford, KE Rodgers - Frontiers in Neuroscience, 2024 - frontiersin.org
Amyotrophic lateral sclerosis (ALS) continues to pose a significant challenge due to the
disease complexity and heterogeneous manifestations. Despite recent drug approvals, there …
disease complexity and heterogeneous manifestations. Despite recent drug approvals, there …
[HTML][HTML] Advancements and challenges in amyotrophic lateral sclerosis
D Bradford, KE Rodgers - Frontiers in Neuroscience, 2024 - ncbi.nlm.nih.gov
Amyotrophic lateral sclerosis (ALS) continues to pose a significant challenge due to the
disease complexity and heterogeneous manifestations. Despite recent drug approvals, there …
disease complexity and heterogeneous manifestations. Despite recent drug approvals, there …
Advancements and challenges in amyotrophic lateral sclerosis
D Bradford, KE Rodgers - Frontiers in neuroscience, 2024 - pubmed.ncbi.nlm.nih.gov
Amyotrophic lateral sclerosis (ALS) continues to pose a significant challenge due to the
disease complexity and heterogeneous manifestations. Despite recent drug approvals, there …
disease complexity and heterogeneous manifestations. Despite recent drug approvals, there …
Advancements and challenges in amyotrophic lateral sclerosis.
D Bradford, KE Rodgers - Frontiers in Neuroscience, 2024 - search.ebscohost.com
Amyotrophic lateral sclerosis (ALS) continues to pose a significant challenge due to the
disease complexity and heterogeneous manifestations. Despite recent drug approvals, there …
disease complexity and heterogeneous manifestations. Despite recent drug approvals, there …
Advancements and challenges in amyotrophic lateral sclerosis.
D Bradford, KE Rodgers - Frontiers in Neuroscience, 2024 - europepmc.org
Amyotrophic lateral sclerosis (ALS) continues to pose a significant challenge due to the
disease complexity and heterogeneous manifestations. Despite recent drug approvals, there …
disease complexity and heterogeneous manifestations. Despite recent drug approvals, there …